11beta-HSD1 inhibitors (Amgen)

N/A

Report date: 2025/06/11 20:01:15

NME

Base Information

Drug Name11beta-HSD1 inhibitors (Amgen)

Drug Alias Name11beta-hydroxysteroid dehydrogenase 1 inhibitors (Biovitrum/Amgen)11beta-HSD1 inhibitors (Biovitrum/Amgen)11beta-hydroxysteroid dehydrogenase 1 inhibitors (Amgen)BVT-12872BVT-2733 +[7]

ClassificationSmall molecules

Mechanisms of ActionCorticosteroid 11-beta-dehydrogenase isozyme 1 inhibitors

TargetsCorticosteroid 11-beta-dehydrogenase isozyme 1

Therapy Area/IndicationsDiabetes Mellitus, Type 2

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritorySweden

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesSwedish Orphan Biovitrum Ab (Publ)

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesSwedish Orphan Biovitrum Ab (Publ)Amgen Inc

Active IndicationsN/A

Inactive IndicationsDiabetes Mellitus, Type 2

Other Information

ATC CodeN/A